Partners4Access

Weekly Roundup: May 18, 2019

Weekly Roundup: May 18, 2019

This week, the team discuss the deal between UK's National Health Service and Biogen prompting the successful reimbursement of Biogen’s Spinraza as a treatment for spinal muscular atrophy and Solid Biosciences’ clinical update on its Duchenne Muscular Dystrophy gene therapy product SGT-001.   Presenter: Aparna Krishnan Contributor: Max Rex Producer: Aparna Krishnan

Duration: 7 min

Release Date:

aparna krishnan max rex national health service biogen solid biosciences spinraza duchenne muscular duchenne muscular dystrophy weekly may 18, 2019 none this week muscular biogen aparna team discuss deal uks
Share part or all of the audio of this episode